In the exploration of self-amplifying mRNA vaccines, such as ARCT-154 produced by Arcturus Therapeutics through their Japanese joint-venture Arcalis, the use of RNA viral RdRP for multiple replications of desired antigens like the spike protein has been discussed.
Concerns have been raised regarding the potential neutralization of such vaccines by treatments like the Zelenko Protocol, which includes zinc and RdRP inhibiting agents, possibly impacting the pharmaceutical industry's investment in mRNA vaccines.
Additionally, there's speculation that "Disease X" could be H5N1, with high fatality rates historically. Zinc supplementation, particularly with a potent zinc ionophore, is proposed as a strategy to mitigate replication of RNA viruses, including H5N1.
Now, attention is turned to the VEEV replicon (RdRP) backbone of ARCT-154, prompting further examination of its implications.
Congratulations @dabullidentity! You have completed the following achievement on the Hive blockchain And have been rewarded with New badge(s)
Your next payout target is 250 HP.
The unit is Hive Power equivalent because post and comment rewards can be split into HP and HBD
You can view your badges on your board and compare yourself to others in the Ranking
If you no longer want to receive notifications, reply to this comment with the word
STOPCheck out our last posts: